GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway.
GPR40 agonist ameliorates liver X receptor-induced lipid accumulation in liver by activating AMPK pathway.
复制标题
GPR40 激动剂通过激活 AMPK 通路改善肝脏 X 受体诱导的肝脏脂质积累
DOI:
10.1038/srep25237
复制
发表时间:
2016-04-28
影响因子:
4.6
通讯作者:
Li J
中科院分区:
文献类型:
--
作者:
Li M;Meng X;Xu J;Huang X;Li H;Li G;Wang S;Man Y;Tang W;Li J
Hepatic steatosis is strongly linked to insulin resistance and type 2 diabetes. GPR40 is a G protein-coupled receptor mediating free fatty acid-induced insulin secretion and thus plays a beneficial role in the improvement of diabetes. However, the impact of GPR40 agonist on hepatic steatosis still remains to be elucidated. In the present study, we found that activation of GPR40 by its agonist GW9508 attenuated Liver X receptor (LXR)-induced hepatic lipid accumulation. Activation of LXR in the livers of C57BL/6 mice fed a high-cholesterol diet and in HepG2 cells stimulated by chemical agonist caused increased expression of its target lipogenic genes and subsequent lipid accumulation. All these effects of LXR were dramatically downregulated after GW9508 supplementation. Moreover, GPR40 activation was accompanied by upregulation of AMPK pathway, whereas the inhibitive effect of GPR40 on the lipogenic gene expression was largely abrogated by AMPK knockdown. Taken together, our results demonstrated that GW9508 exerts a beneficial effect to ameliorate LXR-induced hepatic steatosis through regulation of AMPK signaling pathway.